Medifast Inc (MED) Faces Revenue Decline Amid Market Challenges in Q4 and Full Year 2023 [Yahoo! Finance]
MEDIFAST INC (MED)
Last medifast inc earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.medifastnow.com
Company Research
Source: Yahoo! Finance
Net Income: Q4 net income fell to $6.0 million; full-year net income at $99.4 million, a significant decrease from the prior year. Earnings Per Share (EPS): Q4 EPS was $0.55, with a non-GAAP adjusted EPS of $1.09; full-year EPS stood at $9.10, with a non-GAAP adjusted EPS of $9.64. Gross Margin: Improved to 74.0% in Q4 from 69.3% in the same quarter last year, attributed to cost savings and absence of prior year's restructuring costs. Balance Sheet: Ended the year with $150.0 million in cash, cash equivalents, and investments, and no interest-bearing debt. Outlook: Q1 2024 revenue is expected to be between $155 million to $175 million, with diluted EPS ranging from $0.25 to $0.95. Warning! GuruFocus has detected 3 Warning Signs with MED. On February 20, 2024, Medifast Inc ( NYSE:MED ) released its 8-K filing , detailing the financial results for the fourth quarter and full year ended December 31, 2023. The company, known for its OPTAVIA brand, faced significant revenue de
Show less
Read more
Impact Snapshot
Event Time:
MED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MED alerts
High impacting MEDIFAST INC news events
Weekly update
A roundup of the hottest topics
MED
News
- Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
- Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the FirmAccesswire
- Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y [Yahoo! Finance]Yahoo! Finance
- Medifast, Inc. (NYSE: MED) had its price target lowered by analysts at DA Davidson from $40.00 to $25.00. They now have a "neutral" rating on the stock.MarketBeat
MED
Earnings
- 4/29/24 - Beat
MED
Sec Filings
- 4/29/24 - Form 10-Q
- 4/29/24 - Form 8-K
- 4/26/24 - Form DEF
- MED's page on the SEC website